23rd Anglonordic Europe Life science conference with the reception
London, 20th April, 2027
What makes Anglonordic different?
Built by life science experts, Anglonordic is where Europe’s most promising companies meet the investors and partners who can accelerate their growth
Taking place in London on 20 April 2027, the Anglonordic Europe Life Science Conference brings together innovative biotech, health technology and drug discovery companies with active investors, pharma leaders and strategic partners in a highly curated partnering environment.
Designed around what investors, innovators and industry leaders truly need from a life science event, Anglonordic Europe combines a carefully selected delegate community with an exceptional investor-to-company ratio to create meaningful opportunities for investment, partnerships and collaboration.
With the support of M Ventures as lead and founding sponsor, and a high-quality, sector-focused programme produced by Optimum Strategic Communications, Anglonordic has established itself as a leading life science networking and partnering event and the UK’s unique R&D-to-investor partnering conference.
The Reception is a key part of the conference experience, bringing together investors, innovative companies, pharma leaders and life science partners the evening before the main event at a prestigious London venue.
This exclusive networking opportunity allows delegates to begin building valuable relationships ahead of a focused programme featuring investor-led discussions, cutting-edge presenting companies and 1:1 partnering meetings throughout the conference day.
The earlier you register,
the more you save
Join thousands of biotech, pharma, and investment leaders at Anglonordic Europe Life Science Conference.
Take advantage of the lowest registration rate available today.
JULY 1
2026
SEPT 1
2026
NOV 1
2026
FEB 1
2027
| Registration Period | Industry Delegate Pass | Business Support Pass | Presenting Company Package |
|---|---|---|---|
| Launch Rate 1st July – 31 Aug 2026 |
£595
Save up to 30% |
£850
Save up to 30% |
£950
Save up to 30% |
| Advance Rate 1 Sept – 31 Oct 2026 |
£695
Save up to 20% |
£950
Save up to 20% |
£1,050
Save up to 20% |
| General Registration 1 Nov 2026 – 31 Jan 2027 |
£795
|
£1,095
|
£1,195
|
| Final Registration 1 Feb – 16 April 2027 |
£895
|
£1,250
|
£1,350
|
Investor attendance in 2026































































































































































Past Speakers
No speakers found matching your search.
2027 Speakers
No speakers found matching your search.
Keynote Speaker
Laura Matz, Merck KGaA
Dr. Laura Matz is the Chief Science and Technology Officer at Merck KGaA, where she drives innovation and digitalization across Life Sciences, Healthcare, and Electronics.
Read More
As Executive Vice President, she oversees corporate innovation teams, including new business models. Until early 2025, Laura was also the CEO of Athinia®, a data-sharing platform that enables secure data sharing within the semiconductor ecosystem. Prior to this, she was a Senior Vice President at EMD Electronics (formerly Versum Materials and Air Products Electronics division). She has been a key contributor to semiconductor materials growth, driving strong R&D to enable business success.
Swedish Ambassador’s Residence
22 April, 2026 | 6pm – 8:30pm
We are delighted that the Swedish Ambassador to the UK and Northern Ireland, H.E. Mr. Stefan Gullgren, has kindly invited registered Anglonordic Life Science Conference attendees to a reception at the Ambassador’s Residence in London.
The Reception is now at capacity, kindly do not apply to attend.
Read More
Dress code: Lounge suit.
350+ Attendees
Our attendees are carefully selected to create one of Europe's most valuable life science networking environments, offering unparalleled access to active funding partners, strategic investors, and decision-makers.
Read more...With an exceptional ratio of approximately one active investor for every two companies, the conference hosts meaningful conversations that are difficult to replicate at larger events.
Delegates include:
- CEOs, CSOs and Heads of Business Development from innovative life science companies
- Investment professionals from leading venture capital, private equity and family office funds
- Senior executives and business development leaders from global pharma and biotech
- Key organisations supporting the life science ecosystem
- International country delegations
100+ Active Investors
For more than 22 years, Anglonordic has built a reputation for bringing together one of Europe's strongest communities of active life science investors seeking high-potential healthcare breakthroughs.
Read more...The conference attracts leading venture capital firms, investment funds, and strategic investors. These global premier funders actively look to discover and back high-potential disruptive technologies from small molecule discovery to AI applications and devices.
View the list of investors already signed up
36 Startup Pitches
Discover high-quality, investor-selected growth companies. Pitching opportunities are hand-picked by our expert investor panel from a highly competitive, broad pool of applications.
Read more...We encourage biotech, medtech and technology startups to apply.
Developing ground-breaking technologies, these companies will be seeking funding and/or collaborations.
300+ Partnering Meetings
Connect with the right partners before you arrive. Business discussions start well ahead of the conference through our dedicated 1:1 partnering platform, allowing delegates to plan ahead.
Read more...With detailed company and investor profiles, attendees can easily exchange messages, plan a personalised meeting schedule, and maximise every networking opportunity. At the 2026 conference, more than 300 partnering meetings took place, helping to build vital commercial pipelines.
350+ Attendees
Our attendees are carefully selected to create one of Europe's most valuable life science networking environments, offering unparalleled access to active funding partners, strategic investors, and decision-makers.
Read more...With an exceptional ratio of approximately one active investor for every two companies, the conference hosts meaningful conversations that are difficult to replicate at larger events.
Delegates include:
- CEOs, CSOs and Heads of Business Development from innovative life science companies
- Investment professionals from leading venture capital, private equity and family office funds
- Senior executives and business development leaders from global pharma and biotech
- Key organisations supporting the life science ecosystem
- International country delegations
100+ Active Investors
For more than 22 years, Anglonordic has built a reputation for bringing together one of Europe's strongest communities of active life science investors seeking high-potential healthcare breakthroughs.
Read more...The conference attracts leading venture capital firms, investment funds, and strategic investors. These global premier funders actively look to discover and back high-potential disruptive technologies from small molecule discovery to AI applications and devices.
View the list of investors already signed up
36 Startup Pitches
Discover high-quality, investor-selected growth companies. Pitching opportunities are hand-picked by our expert investor panel from a highly competitive, broad pool of applications.
Read more...We encourage biotech, medtech and technology startups to apply.
Developing ground-breaking technologies, these companies will be seeking funding and/or collaborations.
300+ Partnering Meetings
Connect with the right partners before you arrive. Business discussions start well ahead of the conference through our dedicated 1:1 partnering platform, allowing delegates to plan ahead.
Read more...With detailed company and investor profiles, attendees can easily exchange messages, plan a personalised meeting schedule, and maximise every networking opportunity. At the 2026 conference, more than 300 partnering meetings took place, helping to build vital commercial pipelines.
Charity of the Year
“We are delighted to have been chosen as charity of the year for the 2026 Anglonordic Life Science conference. Barts Charity exists to support healthier, longer lives in East London, where our patients face some of the greatest health inequalities in the UK. Healthcare innovation is urgently needed, and this opportunity will help us build relationships with leading drug discovery and technology companies across the UK, Nordic and European regions, collaborating to accelerate discoveries and improved patient care.”
– Fiona Miller-Smith, CEO at Barts Charity
Find out moreEvent sponsors
























Media and industry partners


















